CrossCare 2.0

MindSpeaker BCI was a winner of the 2024 inter-regional ("Interreg") CareTech innovation grant. 

The CrossCare project stimulates, supports, and accelerates innovations in healthcare. CrossCare contributes to the development and implementation of healthcare innovations (product, service, concept) by providing a living lab environment and has a fund to support innovation projects. CrossCare offers an accessible pathway to achieving healthcare innovation on a larger scale.It is a cross-border project of Interreg Flanders-Netherlands and provides both practical and financial support. Since CrossCare has eight living labs in Flanders and the Netherlands, healthcare innovations can be tested and further developed by end users. Slimmer Leven, together with its members, is one of these eight living labs where SMEs can conduct testing.

During the first successful CrossCare project (2016-2021), Flemish and Dutch living labs supported 30 healthcare innovations. On Wednesday, May 17, 2023, INTERREG Flanders-Netherlands approved the successor project, ‘CrossCare 2.0’. Over the next three years, CrossCare 2.0 will continue along the same path, once again facilitating the development and implementation of innovations in the healthcare and welfare sector.

On the one hand, companies and healthcare organizations developing innovations can receive financial support from the CrossCare Innovation Fund, with grants of up to €100,000 per organization. On the other hand, living labs on both sides of the border will support the selected companies and healthcare organizations by demonstrating, testing, and evaluating innovations with end users.The living labs are experts in co-creation and live testing with healthcare users and professionals in their own living and working environments. They offer this expertise free of charge within this project.